NIH has recently launched Rapid Acceleration of Diagnostics (RADx), an initiative that aims to speed development, delivery, and use of COVID-19 testing technologies.
As part of this initiative, NIH has issued new Notices and a Request For Application for the RADx Underserved Populations (RADx-UP) program, which is seeking research applications to expand access to and acceptance of testing in underserved and/or vulnerable populations that have been disproportionately affected by the pandemic.
- Emergency Competitive Revisions for Social, Ethical, and Behavioral Implications Research on COVID-19 Testing Among Underserved and/or Vulnerable Populations
- Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations
- Limited Competition for Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations
- RADx-UP Coordination and Data Collection Center (U24 Clinical Trial Optional)
Learn more about RADx